17^th International Conference on Nephrology & Urology March 12-13, 2018 London , UK

Dr. Segal received a B.S. degree in Biology from MIT in 1984. As an undergraduate he did research in the laboratory of Dr. Monty Krieger studying the alteration in the glycosylation pattern of a cell line defective in LDL receptor endocytosis. After graduating from MIT, Dr. Segal was accepted into the MSTP M.D./Ph.D. training program at the University of Texas Southwestern Medical School.

Dr. Segal's research focuses on the mechanisms of the increased cardiovascular disease in patients with diabetes, chronic kidney disease, systemic lupus erythematosus (SLE), and women who have preeclampsia or preterm delivery. His hypothesis is that a key determinate of whether an individual will develop chronic kidney disease or atherosclerosis is the ability of the individual's endothelium to tolerate their level of blood pressure, glycemia, or other stressors to the endothelium.

Dr. Allen obtained PhD in Medicine in 1978. For many years he was treated patients with chronic internal diseases, including various kidney problems: nephritis, nephrosis, chronic kidney failure and kidney stones, developing diets for them. Later Dr Allen headed health clinic for the treatment of chronic internal conditions. Then he devoted two decades to further medical research and developed Thermobalancing therapy® and Dr Allen’s Devices for chronic internal diseases, which received a patent in the USA, as “Therapeutic device and method”. He is Director of Fine Treatment, United Kingdom, the Company that distributes these devices worldwide.

chronic internal diseases.

Tong Wang completed her M.D. and clinical trainings at Beijing University, School of Medicine in China. She then spent two postdoctoral training periods in the United States, first at the University of Illinois at Chicago and later at Yale University School of Medicine (with Dr. Gerhard Giebisch). Currently, she is a full Professor, Director of the Small Animal Physiology Core in the Department of Cellular and Molecular Physiology and is co-Director of the Renal Physiology Core in the George M O'Brien Kidney Center at Yale University. She has published more than 100 papers in reputed journals and has been serving as an active member of NIH KMBD study section.

Renal Physiology , Cellular and Molecular Physiology

Riitta Lassila has completed her MD in 1983 from Helsinki University, PhD in 1989, and postdoctoral studies at Mount Sinai University School of Medicine in N.Y. She is an internist and the Head of Coagulation Disorders Unit in Helsinki University Hospital since 2000 and Professor of Coagulation Medicine in Helsinki University since 2013. She has published more than 220 papers in peer-reviewed journals and has served as editor in Thrombosis Research and editorial board member of Haemophilia. She is the secretary of European Association of Haemophilia and Allied Disorders and steering committee member of EUHANET and EUHASS. She is CSO in Aplagon Oy developing APACs as pharamceutical entities.

Coagulation Medicine